We characterized GPNMB as a downstream target of TFE3, whose expression was strictly dependent on FLCN inactivation in cultured cells, kidneys of Flcn knockout mouse models, and kidney tumors from BHD patients (a working model is shown in Fig. S5). The gene discussed is TFE3; the disease is Birt-Hogg-Dube syndrome.